Literature DB >> 20472270

MicroRNAs: a new paradigm on molecular urological oncology.

Leonardo Oliveira Reis1, Tiago Campos Pereira, Iscia Lopes-Cendes, Ubirajara Ferreira.   

Abstract

MicroRNAs (miRNA) are a class of naturally occurring, small, noncoding RNAs that function as specific repressors of protein-encoding genes, being pivotal regulators of development and cellular homeostasis. They have been functionally classified as proto-oncogenes or tumor suppressors and are aberrantly expressed in different cancer types. Deregulation of these so-called "cancerous" miRNAs can figure prominently in tumor initiation and progression. The Human miRNA profile is under development, and it is of concern that there is so little agreement on the miRNAs found in each of the studies. Bioinformatics progress and efficient delivery are essential to overcome barriers to miRNA use in clinical practice.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472270     DOI: 10.1016/j.urology.2010.03.012

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.

Authors:  Yu-Zheng Ge; Ran Wu; Hui Xin; Meng Zhu; Tian-Ze Lu; Hao Liu; Zheng Xu; Peng Yu; You-Cai Zhao; Ming-Hao Li; Zhi-Kai Hu; Yan Zhao; Bing Zhong; Xiao Xu; Liu-Hua Zhou; Lu-Wei Xu; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-30       Impact factor: 4.553

2.  Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients.

Authors:  Marianna Pelloni; Giulia Coltrinari; Donatella Paoli; Francesco Pallotti; Francesco Lombardo; Andrea Lenzi; Loredana Gandini
Journal:  Endocrine       Date:  2016-10-28       Impact factor: 3.633

Review 3.  Old issues and new perspectives on prostate cancer hormonal therapy: the molecular substratum.

Authors:  Leonardo Oliveira Reis
Journal:  Med Oncol       Date:  2011-05-28       Impact factor: 3.064

Review 4.  MiR-146a rs2910164 polymorphism increases risk of gastric cancer: a meta-analysis.

Authors:  Wen-Qun Xie; Shi-Yun Tan; Xiao-Fan Wang
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.

Authors:  K-P Dieckmann; M Spiekermann; T Balks; I Flor; T Löning; J Bullerdiek; G Belge
Journal:  Br J Cancer       Date:  2012-10-11       Impact factor: 7.640

Review 6.  Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis.

Authors:  Jenny E Elzinga-Tinke; Gert R Dohle; Leendert Hj Looijenga
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

7.  MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.

Authors:  YaSai Yao; Jian Hu; Zan Shen; RuYong Yao; ShiHai Liu; Yong Li; Hui Cong; XinGang Wang; WenSheng Qiu; Lu Yue
Journal:  J Cell Mol Med       Date:  2015-01-30       Impact factor: 5.310

Review 8.  Circulating microRNAs in malaria infection: bench to bedside.

Authors:  Supat Chamnanchanunt; Suthat Fucharoen; Tsukuru Umemura
Journal:  Malar J       Date:  2017-08-15       Impact factor: 2.979

9.  miR-146a C/G polymorphism increased the risk of head and neck cancer, but overall cancer risk: an analysis of 89 studies.

Authors:  Dezhong Sun; Xiaoyan Zhang; Xiaolei Zhang
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

10.  Clinical Diagnostic Implications of Body Fluid MiRNA in Oral Squamous Cell Carcinoma: A Meta-Analysis.

Authors:  Xiujuan Tian; Zhiying Chen; Shaomin Shi; Xianwen Wang; Wanli Wang; Ning Li; Jing Wang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.